# Hangzhou Talent Group

> Hangzhou Talent Group is a VC fund backing Biotechnology, Medical and Biopharma. See 8 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 8
- Last investment: Jul 2026
- Lead investor: 13%
- Last updated: Aug 2026
- Website: https://www.hzsrcjt.com/

Hangzhou Talent Group is an business organization.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 50% |
| Medical | 2 | 25% |
| Biopharma | 2 | 25% |
| Health Care | 2 | 25% |
| Artificial Intelligence | 2 | 25% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 38% |
| Seed | 2 | 25% |
| Series B | 1 | 13% |
| Series C | 1 | 13% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Yuannang Bio | Yuannang Bio is an innovative biotechnology company dedicated to the research, development, and commercialization of nanovesicle-based therapeutic technologies. |  | Series A | Jul 22, 2026 |  |
| Longxing Avionics | Longxing Avionics is a domestic avionics manufacturer focusing on large aircraft industry, developing airborne equipments like WQAR, ELT, and IP Phone, and aiming to build a comprehensive service provider. | $14.7M | Series A | Jun 30, 2026 |  |
| Anquan Digital Intelligence | Anquan Digital Intelligence is an internet security technology service provider specializing in network security breach detection and defense, data risk and protection, artificial intelligence. |  | Seed | Feb 03, 2026 |  |
| Quanzhentong | Quanzhentong specializes in medical AI products and services, utilizing its comprehensive platform in numerous hospitals. It uses natural language processing, image recognition, and speech recognition to guide and pre-diagnose patients, generate medical records, analyze symptoms, and provide intelligent auxiliary diagnosis suggestions. It alsohandles tedious tasks, improves work efficiency, and offers personalized medical service suggestions. |  | Series B | Dec 15, 2025 |  |
| SynRx Therapeutics | Sanctuary Bio is a DNA damage repair drug developer, focusing on the field of DNA damage repair. | $14.1M | Series A | Dec 08, 2025 |  |
| Kind Pharmaceutical | Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs. The company was founded in 2013 and is headquartered in Redwood City, California, United States. | $56.2M | Series C | Nov 12, 2025 |  |
| Longxing Avionics | Longxing Avionics is a domestic avionics manufacturer focusing on large aircraft industry, developing airborne equipments like WQAR, ELT, and IP Phone, and aiming to build a comprehensive service provider. | $13.9M | Series A | Jun 10, 2025 |  |
| Gaowei Medicine | Gaowei Medicine is a drug discovery platform for developing new drugs for key intractable diseases such as cancer and neurological diseases. |  | Seed |  |  |

8 of 8 investments shown.

## Co-investors
- [Hangzhou Capital](https://shizune.co/investors/profile/hangzhou-capital) — VC Fund, 2 deals together
- [Hangzhou Low Altitude Industry Development](https://shizune.co/investors/profile/hangzhou-low-altitude-industry-development) — VC Fund, 2 deals together
- [Huayu Venture Capital](https://shizune.co/investors/profile/huayu-venture-capital-25bc) — VC Fund, 2 deals together
- [Puhua Capital](https://shizune.co/investors/profile/puhua-capital) — VC Fund, 2 deals together
- [Gaorong Capital](https://shizune.co/investors/profile/banyan-capital) — VC Fund, 1 deal together
- [Biomedicine and High-end Equipment Industry Fund](https://shizune.co/investors/profile/biomedicine-and-high-end-equipment-industry-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Hangzhou Talent Group invest in?

Hangzhou Talent Group invests primarily in Biotechnology, Medical and Biopharma startups, most often at Series A and Seed stage. Most of the 8 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Hangzhou Talent Group last invest?

The most recent investment recorded for Hangzhou Talent Group closed in Jul 2026. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co